Subacute cutaneous lupus erythematosus-like drug eruption after durvalumab treatment for squamous cell carcinoma.

Subacute cutaneous lupus erythematosus secondary to intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyneuropathy: A case report.

A Case Report of a Rare Subacute Cutaneous Lupus Erythematosus with Chin Prostration.

Subacute cutaneous lupus erythematosus in a patient with Whipple's disease.

Bispecific Antibody-Associated Subacute Cutaneous Lupus Erythematosus: A Novel Autoimmune Complication in Cancer Immunotherapy.

Nivolumab-induced subacute cutaneous lupus erythematosus in a patient with sigmoid colon cancer: a case report and review of the literature.

Efficacy of Belimumab on Different Joint and Skin Manifestations of Systemic Lupus Erythematosus: Real-Life Data from a New Multicentric, Nationwide Italian Cohort (BeRLiSS-JS 2.0).

Decreased Plasmacytoid Dendritic Cells in Cutaneous Squamous Cell Carcinoma Arising From Subacute Cutaneous Lupus Erythematosus: A Case Report.

A case of trastuzumab-deruxtecan-induced subacute cutaneous lupus erythematous.

Tinea Incognito Caused by Microsporum spp. Mimicking Subacute Cutaneous Lupus Erythematosus-Case Report.

Toxic epidermal necrolysis-like subacute cutaneous lupus erythematosus following pembrolizumab therapy.

Anifrolumab for Nonsystemic Cutaneous Lupus Erythematosus: Clinical Experience, Immunologic Insights, and Review of the Literature.

A striking case of cutaneous adult T-cell leukemia/lymphoma mimicking subacute cutaneous lupus erythematosus.

A Case of Rowell Syndrome: Excellent Response to Oral Cyclosporine.

Evolution of Subacute Cutaneous Lupus Erythematosus.

Drug-induced subacute cutaneous lupus erythematous from cenobamate: case presentation and review of the literature.

The patterns of recurrence in cutaneous lupus erythematosus: A retrospective analysis of subacute cutaneous lupus erythematosus and discoid lupus erythematosus flares.

Subacute Cutaneous Lupus Erythematosus Triggered by Radiation Therapy.

Subacute cutaneous lupus erythematosus triggered by sintilimab: a case report.

Verification of biological markers of subacute cutaneous lupus erythematosus via TMT labelling proteomics combined with transcriptome data.

Case Report: Subacute cutaneous lupus erythematosus induced by the anti-PD-1 antibody camrelizumab combined with chemotherapy.

Successful treatment of subacute cutaneous lupus erythematosus with the TYK-2 inhibitor deucravacitinib in a patient with concomitant psoriasis vulgaris.

The Steroid Veil: Complications in Identifying Lupus.

Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Fenofibrate Lipid Lowering Agent.

Pembrolizumab- induced subacute cutaneous lupus erythematosus in a patient with oropharyngeal squamous cell carcinoma: A case report and literature review.

A photodistributed rash in a patient on apixaban.

Phototoxic reaction to oral terbinafine due to Tinea capitis in a child.

Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome in a patient with subacute cutaneous lupus (SCLE).

Pustular and crusted lesions in systemic lupus erythematosus: A case report.

Drug-Associated Risk of Subacute Cutaneous Lupus Erythematosus: A Pharmacovigilance Study of the FDA Adverse Event Reporting System.

[Systemic lupus erythematosus involving the fornix column leading to hyponatremia: A case report].

A review on toxic epidermal necrolysis-like superficial wound lesions: Issue and challenge on 10 clinical entities.

Drug-induced subacute cutaneous lupus erythematosus involving osimertinib.

Acrodermatitis Enteropathica: A Case Report Involving a Delayed Diagnosis.

Clinical characteristics, treatment and outcome of subacute cutaneous lupus erythematosus induced by PD-1/PD-L1 inhibitors.

Subacute cutaneous lupus erythematosus following osimertinib therapy for non-small cell lung cancer: A case report.

Drug-induced subacute cutaneous lupus erythematosus secondary to Dupilumab: A case report.

Performance of the Systemic Lupus Erythematosus Risk Probability Index (SLERPI) in a cohort of Colombian population.

Analysis of clinical characteristics of terbinafine-induced subacute cutaneous lupus erythematosus.

Subacute Cutaneous Lupus Erythematosus Secondary to Intravenous Immunoglobulin Infusions.

Systemic Lupus Erythematosus Complicated with Mycobacterium Leprae Infection: a Rare Case Report.

Lupus Erythematosus Tumidus as a Distinct Uncommon Subtype of Cutaneous Lupus Erythematosus: A Case Report and Review.

Association of the Spectrum of Cutaneous Lupus Erythematosus with Disease Activity and Systemic Manifestations in Patients with Systemic Lupus Erythematosus.

A case of terbinafine-induced subacute cutaneous lupus erythematosus rapidly resolving with upadacitinib.

Palbociclib-induced subacute cutaneous lupus erythematosus.

[Paraneoplastic subacute cutaneous lupus erythematosus].

Immune checkpoint inhibitor-induced subacute cutaneous lupus erythematosus: a case report and review of the literature.

Dermoscopy for the Differentiation of Subacute Cutaneous Lupus Erythematosus from Other Erythematous Desquamative Dermatoses-Psoriasis, Nummular Eczema, Mycosis Fungoides and Pityriasis Rosea.

Manifestation of subacute cutaneous lupus erythematosus during treatment with anti-PD-1 antibody cemiplimab - a case report.

Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE.

Rapid clinical improvement of refractory subacute cutaneous lupus erythematosus with oral tyrosine kinase 2 inhibitor deucravacitinib: A case report.

Comprehensive Evaluation of Neuropsychiatric and Mucocutaneous Manifestations in the Diagnosis of Systemic Lupus Erythematosus: A Complete Clinical Approach to a Case.

Cutaneous Toll-like Receptor 9 Pre-Defines Hydroxychloroquine Dosage in Patients with Both Discoid and Subacute Lupus Erythematosus.

Cutaneous Lupus Erythematosus: Review and Considerations for Older Populations.

Subacute cutaneous lupus erythematosus versus discoid lupus erythematosus: A challenging diagnosis.

Toxic epidermal necrolysis-like subacute cutaneous lupus erythematosus associated with breast cancer.

Change in disease activity needed for meaningful change in cutaneous lupus by patient characteristic: A retrospective analysis of a longitudinal database.

Subacute cutaneous lupus erythematosus with a psoriasiform presentation: A diagnostic clinical conundrum.

The Possible Clinical Significance of a Decreased Serum Level of Soluble PD-L1 in Discoid Lupus Erythematosus, but Not in Subacute Cutaneous Lupus Erythematosus-A Pilot Study.

Successful treatment of refractory subacute cutaneous lupus erythematosus with deucravacitinib.

Propofol Induced Subacute Cutaneous Lupus Erythematosus: A Case Report.

Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer.

Rowell Syndrome in a Middle-Aged Woman: A Case Report.

Role of Anifrolumab in Refractory Cutaneous Manifestations of Lupus Erythematosus: A Case Series and Literature Review.

A case of reactive granulomatous dermatitis associated with neonatal lupus erythematosus.

Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study.

Ocular Discoid Lupus Erythematosus: More Than what Meets The Eye.

Collagen Vascular Diseases: A Review of Cutaneous and Systemic Lupus Erythematosus, Dermatomyositis, and Distinguishing Features in Skin of Color.

Subacute cutaneous lupus erythematosus as a rare complication of disease-modifying therapy administration in multiple sclerosis: case report.

Panoramic view of clinical features of lupus erythematosus: a cross-sectional multicentre study from China.

Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.

Subacute cutaneous lupus erythematosus induced by Pfizer COVID-19 vaccine.

Subacute cutaneous lupus erythematosus after COVID-19 vaccine.

The association between subacute cutaneous lupus erythematosus and malignancy.

Subacute cutaneous lupus erythematosus after mRNA-based SARS-CoV-2 vaccination.

Differential effect of the 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus on different cutaneous lupus subtypes.

Paraneoplastic subacute cutaneous lupus erythematosus in a patient with metastatic melanoma.

Neonatal lupus erythematosus presenting as a non-bullous histiocytoid neutrophilic dermatosis.

Autoimmunity-related neutrophilic dermatosis after coronavirus disease 2019 vaccination: A case report and literature review.

A case of Rowell syndrome with excellent improvement following anifrolumab.

Subacute cutaneous lupus erythematosus successfully treated with topical delgocitinib.

Deucravacitinib in moderate-to-severe psoriasis.

Single-cell transcriptome reveals immunopathological cell composition of skin lesions in subacute cutaneous lupus erythematosus.

Cutaneous lupus erythematosus flare with vitiligo-like depigmentation following the AstraZeneca COVID vaccine.

Apremilast for the Treatment of Concomitant Subacute Cutaneous Lupus Erythematosus and Psoriasis.

Proton pump inhibitor-induced subacute cutaneous lupus erythematosus.

Proton pump inhibitors-related subacute cutaneous lupus erythematosus: Clinical characteristics, management, and outcome.

Identification of Significant Genes and Pathways for the Chronic and Subacute Cutaneous Lupus Erythematosus via Bioinformatics Analysis.

Concomitant nondermatologic adverse events in patients who develop immunotherapy-induced subacute cutaneous lupus erythematosus.

Clinicopathological characteristics of cutaneous lupus erythematosus patients in Bangladesh.

Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus.

Subacute cutaneous lupus erythematosus: A facultative paraneoplastic dermatosis.

Dermoscopic Features of Acute, Subacute, Chronic and Intermittent Subtypes of Cutaneous Lupus Erythematosus in Caucasians.

Post-Irradiation Morphea of the Breast in a Patient with Subacute Cutaneous Lupus Erythematosus: Case Report and a Literature Review.

Subacute cutaneous lupus erythematosus induced by Capecitabine: Confocal microscopy and dermoscopy findings.

Ethambutol-induced subacute cutaneous lupus erythematosus.

CAN SKIN BE A MARKER FOR INTERNAL MALIGNANCY? EVIDENCE FROM CLINICAL CASES.

Nivolumab-Induced de novo Discoid Lupus Erythematosus.

Proton pump inhibitor induced subacute cutaneous lupus erythematosus: Clinical characteristics and outcomes.

Subacute cutaneous lupus erythematosus following ChAdOx1 nCoV-19 vaccination.

B cell depletion therapy using rituximab to induce long-term remission of recalcitrant skin lesions of subacute cutaneous lupus erythematosus.

Prominent B-Cell Signature Differentiates Discoid from Subacute Cutaneous Lupus Erythematosus.

Amlodipine-Induced Subacute Cutaneous Lupus Erythematosus Localized to Non-Sun-Exposed Areas.

Papulonodular Mucinosis Associated With Subacute Lupus.

Positive Antinuclear Antibody (ANA)-Negative Systemic Lupus Erythematosus (SLE) Presenting With Acute Pancreatitis.

Paraneoplastic subacute cutaneous lupus erythematosus with mucositis.

Skin CD4+ Trm cells distinguish acute cutaneous lupus erythematosus from localized discoid lupus erythematosus/subacute cutaneous lupus erythematosus and other skin diseases.

Annular scaly plaques with peripheral pustules.

Case Report: Rowell Syndrome-Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 Infection.

Subacute Cutaneous Lupus as a Paraneoplastic Manifestation of Non-Hodgkin Lymphoma.

A case of belatacept-induced chilblain lupus.

Proton Pump Inhibitor Induced Subacute Cutaneous Lupus Erythematosus: A Case Series of 7 Patients and Brief Review of Literature.

Colocalisation of subacute cutaneous lupus erythematosus and vitiligo in a woman with thyroid autoantibodies: An intriguing association.

Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by Durvalumab: A Case Report and Literature Review.

Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis.

Dermatological adverse effects of anti-glaucoma eye drops: a review.

Radiation-induced subacute cutaneous lupus erythematosus.

Annular lichenoid diseases.

Cutaneous Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors and Their Management.

B Cell Signatures Distinguish Cutaneous Lupus Erythematosus Subtypes and the Presence of Systemic Disease Activity.

Baricitinib for recalcitrant subacute cutaneous lupus erythematosus with concomitant frontal fibrosing alopecia.

Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 vaccine in a patient with primary biliary cholangitis.

Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib.

A Curious Case of Drug-induced Subacute Cutaneous Lupus Erythematosus.

Subacute Cutaneous Lupus Erythematosus: Diagnosis and Follow Up by Dermoscopy.

A case of paraneoplastic subacute cutaneous lupus erythematosus in a patient with metastatic melanoma.

Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine.

COVID-19 and exacerbation of dermatological diseases: A review of the available literature.

Atypical Subacute Cutaneous Lupus in a Patient on Apixaban Anticoagulation Therapy: A Case Report and Review of the Literature.

Cutaneous lupus erythematosus mimicking radiation dermatitis in a patient with breast cancer.

Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination.

Belimumab in subacute cutaneous lupus erythematosus.

Subacute cutaneous lupus erythematosus following abemaciclib therapy for metastatic breast cancer.

A Case of Subacute Cutaneous Lupus Erythematosus and Review of Cutaneous Lupus Clinical Variants.

Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report.

Gene Expression Profiling in the Skin Reveals Strong Similarities between Subacute and Chronic Cutaneous Lupus that Are Distinct from Lupus Nephritis.

A chronic nonresponsive facial eruption.

Cutaneous Manifestations of "Lupus": Systemic Lupus Erythematosus and Beyond.

Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine.

Recognition and Management of Cutaneous Connective Tissue Diseases.

Clinical features of tumor necrosis factor-α-inhibitor induced chilblain lupus: A case series.

Expression pattern of tissue-resident memory T cells in cutaneous lupus erythematosus.

Drug-induced subacute cutaneous lupus erythematosus in previously diagnosed systemic lupus erythematosus patients: A case series.

Subacute cutaneous Lupus erythematosus induced by dupilumab: a novel possible association with specific pathogenetic mechanisms.

Leprosy as a Diagnostic Challenge in the United States.

Neuropsychiatric manifestations in an adolescent male with Rowell syndrome.

Dermoscopic Appearance of an Annular Subacute Cutaneous Lupus Erythematosus.

NKG2D and its ligands as cytotoxic factors in cutaneous lupus erythematosus.

Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience.

Subacute cutaneous lupus erythematosus triggered after measles vaccination.

Brodalumab-induced subacute cutaneous lupus erythematosus.

Tofacitinib-induced subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis.

Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy.

Subacute cutaneous lupus erythematosus induced by PD-1 Inhibitor therapy: two case reports and literature review.

Subacute cutaneous lupus erythematosus in a patient with Sjögren's syndrome taking terbinafine for onychomycosis.

Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer.

Drug-induced subacute cutaneous lupus erythematosus associated with abatacept.

Multiple drugs as inducing or exacerbating agents in subacute cutaneous lupus erythematosus.

Alendronate induced subacute cutaneous lupus erythematosus successfully treated with intravenous immunoglobulin.

Prevalence of antimitochondrial antibodies in subacute cutaneous lupus erythematosus.

Systematic Review: Monoclonal Antibody-Induced Subacute Cutaneous Lupus Erythematosus.

Higher specificity of the new EULAR/ACR 2019 criteria for diagnosing systemic lupus erythematosus in patients with biopsy-proven cutaneous lupus.

De novo subacute cutaneous lupus erythematosus-like eruptions in the setting of programmed death-1 or programmed death ligand-1 inhibitor therapy: clinicopathological correlation.

Terbinafine-induced lichenoid drug eruption: case report and review of terbinafine-associated cutaneous adverse events.

Association Between Drug Use and Subsequent Diagnosis of Lupus Erythematosus.

A case of recombinant human follitropin alfa-induced subacute cutaneous lupus erythematosus presenting with erythema multiforme-like lesion.

Vitiligo-like depigmentation subsequent to subacute cutaneous lupus erythematosus and hydroxychloroquine treatment.

Vesiculobullous Subacute Cutaneous Lupus Erythematosus: A Rare Presentation.

Omeprazole-Induced Subacute Cutaneous Lupus Erythematosus.

Discoid Lupus Erythematosus Lesions Associated with Systemic Fluorouracil Agents: A Case Report and Review.

Secukinumab-induced subacute cutaneous lupus erythematosus.

Subacute cutaneous lupus erythematosus with melanocyte elimination induced by pembrolizumab.

Subacute cutaneous lupus erythematosus with positive anti-Ro antibodies following palbociclib and letrozole treatment: A case report and literature review.

Drug-induced anti-Ro positive subacute cutaneous lupus in a man treated with olmesartan.

Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature.

Anastrozole-Induced Dermatitis: Report of a Woman with an Anastrozole-Associated Dermatosis and a Review of Aromatase Inhibitor-Related Cutaneous Adverse Events.

Successful ustekinumab treatment in a patient with psoriasis and subacute cutaneous lupus erythematosus.

Three cases of subacute cutaneous lupus erythematosus associated with malignancy: a late paraneoplastic phenomenon.

Childhood subacute cutaneous lupus erythematosus associated with transaminitis.

Subacute cutaneous lupus erythematosus with a possible paraneoplastic association with melanoma.

Capecitabine-induced Subacute Cutaneous Lupus Erythematosus.

Widespread subacute cutaneous lupus erythematosus in a patient receiving checkpoint inhibitor immunotherapy with ipilimumab and nivolumab.

UV radiation exposure in welders: impact on the skin and eyes.

Clinicopathologic comparison of Rowell syndrome, erythema multiforme, and subacute cutaneous lupus erythematosus.

Toxic epidermal necrolysis-like subacute cutaneous lupus erythematosus associated with lung carcinoma.

[Immunohistochemical analysis for C3d, C4d, IgG, IgG4, and CD123 in diagnosis of autoimmune skin diseases].

Metastatic prostate cancer presenting as subacute cutaneous lupus erythematosus.

Rowell's Syndrome Triggered by Omeprazole.

Subacute cutaneous lupus erythematosus induced by gemcitabine in 2 patients with pancreatic cancer.

Cutaneous effects of antihypertensive drugs.

Subacute Cutaneous Lupus Erythematosus in a Male Patient on Multiple Antiepileptics Unmasked by Melatonin.

Heterogeneous lupus-specific lesions and treatment outcome, in a single patient, over a period of time.

Subacute cutaneous lupus erythematosus leukoderma treated with melanocyte-keratinocyte transplantation procedure.

Primary antiphospholipid syndrome during aromatase inhibitors therapy: A case report and review of the literature.

Ustekinumab-induced subacute cutaneous lupus.

Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study.